CN111920742A - 一种壳聚糖多效修复面膜及制备方法 - Google Patents
一种壳聚糖多效修复面膜及制备方法 Download PDFInfo
- Publication number
- CN111920742A CN111920742A CN202010987230.7A CN202010987230A CN111920742A CN 111920742 A CN111920742 A CN 111920742A CN 202010987230 A CN202010987230 A CN 202010987230A CN 111920742 A CN111920742 A CN 111920742A
- Authority
- CN
- China
- Prior art keywords
- parts
- chitosan
- extract
- preparation
- sodium hyaluronate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001661 Chitosan Polymers 0.000 title claims abstract description 83
- 230000008439 repair process Effects 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 39
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 29
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 29
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 29
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000008367 deionised water Substances 0.000 claims abstract description 15
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 15
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 14
- 229960000458 allantoin Drugs 0.000 claims abstract description 14
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims abstract description 13
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229940101267 panthenol Drugs 0.000 claims abstract description 13
- 235000020957 pantothenol Nutrition 0.000 claims abstract description 13
- 239000011619 pantothenol Substances 0.000 claims abstract description 13
- 239000003755 preservative agent Substances 0.000 claims abstract description 10
- 230000002335 preservative effect Effects 0.000 claims abstract description 10
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims abstract description 10
- 229960000401 tranexamic acid Drugs 0.000 claims abstract description 10
- 229940069521 aloe extract Drugs 0.000 claims abstract description 8
- 229940083980 lavender extract Drugs 0.000 claims abstract description 8
- 235000020723 lavender extract Nutrition 0.000 claims abstract description 8
- 239000000126 substance Substances 0.000 claims abstract description 8
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 6
- 230000001737 promoting effect Effects 0.000 claims abstract description 6
- 229940059958 centella asiatica extract Drugs 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims abstract description 5
- 239000012528 membrane Substances 0.000 claims abstract description 3
- 238000003756 stirring Methods 0.000 claims description 29
- 230000001815 facial effect Effects 0.000 claims description 24
- 239000000499 gel Substances 0.000 claims description 23
- 239000007787 solid Substances 0.000 claims description 14
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 8
- 238000001694 spray drying Methods 0.000 claims description 7
- 229920001577 copolymer Polymers 0.000 claims description 6
- 230000006196 deacetylation Effects 0.000 claims description 6
- 238000003381 deacetylation reaction Methods 0.000 claims description 6
- 239000000419 plant extract Substances 0.000 claims description 5
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 4
- 229920002907 Guar gum Polymers 0.000 claims description 4
- 239000002211 L-ascorbic acid Substances 0.000 claims description 4
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 4
- 229960005070 ascorbic acid Drugs 0.000 claims description 4
- 229960004106 citric acid Drugs 0.000 claims description 4
- 239000000665 guar gum Substances 0.000 claims description 4
- 229960002154 guar gum Drugs 0.000 claims description 4
- 235000010417 guar gum Nutrition 0.000 claims description 4
- 229920000609 methyl cellulose Polymers 0.000 claims description 4
- 239000001923 methylcellulose Substances 0.000 claims description 4
- 235000010981 methylcellulose Nutrition 0.000 claims description 4
- BONNRKLSQRLNHV-UHFFFAOYSA-N n-methylmethanamine;prop-2-enamide Chemical compound CNC.NC(=O)C=C BONNRKLSQRLNHV-UHFFFAOYSA-N 0.000 claims description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 4
- 229960005323 phenoxyethanol Drugs 0.000 claims description 4
- 229960004889 salicylic acid Drugs 0.000 claims description 4
- 229940104261 taurate Drugs 0.000 claims description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 4
- 229960000583 acetic acid Drugs 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 230000002421 anti-septic effect Effects 0.000 claims description 2
- 125000002091 cationic group Chemical group 0.000 claims description 2
- 229920006037 cross link polymer Polymers 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 2
- 206010000496 acne Diseases 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 17
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 15
- 239000008280 blood Substances 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 10
- 239000002994 raw material Substances 0.000 abstract description 7
- 238000010521 absorption reaction Methods 0.000 abstract description 5
- 239000002775 capsule Substances 0.000 abstract description 4
- 239000013543 active substance Substances 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 3
- 230000036620 skin dryness Effects 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 46
- 239000000284 extract Substances 0.000 description 15
- 239000000843 powder Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- 239000000047 product Substances 0.000 description 7
- 239000004005 microsphere Substances 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 229910001385 heavy metal Inorganic materials 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 229920002674 hyaluronan Polymers 0.000 description 4
- 229960003160 hyaluronic acid Drugs 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 239000003094 microcapsule Substances 0.000 description 4
- 206010040844 Skin exfoliation Diseases 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 3
- 239000000052 vinegar Substances 0.000 description 3
- 235000021419 vinegar Nutrition 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 241000208680 Hamamelis mollis Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 235000020221 chamomile extract Nutrition 0.000 description 2
- 229940119217 chamomile extract Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229940092258 rosemary extract Drugs 0.000 description 2
- 235000020748 rosemary extract Nutrition 0.000 description 2
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 2
- 230000037307 sensitive skin Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 229940118846 witch hazel Drugs 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 241000167550 Centella Species 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010048218 Xeroderma Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229940039697 alkanna tinctoria root extract Drugs 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 206010021198 ichthyosis Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000036619 pore blockages Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 229940064064 purslane extract Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种壳聚糖多效修复面膜及制备方法。其技术方案是:其组成组分包括如下,按重量份:壳聚糖1‑6份,促成膜物质,1‑6份,积雪草提取液1‑10份,人参提取液1‑10份,薰衣草提取液1‑10份,芦荟提取液1‑10份,甘油1‑10份,透明质酸钠0.01‑0.2份,传明酸0.3‑2份,三甲基甘氨酸1‑10份,泛醇0.1‑5份,尿囊素0.1‑2份,凝胶剂0.1‑5份,防腐剂0.1‑0.5份,剩余组分为去离子水补足100份。有益效果是:本发明充分利用壳聚糖的结构特性,形成双层胶囊结构,极大加强了各种活性物质的吸收,并且可以缓释,持续发挥各种原料的功效,改善皮肤干裂,粗糙,痘印,痤疮,粉刺,红血丝等问题,修复皮肤,恢复皮肤健康。
Description
技术领域
本发明涉及护肤品技术领域,特别涉及一种壳聚糖多效修复面膜及制备方法。
背景技术
随着现代社会生活环境的日益恶化,和科技进步带来的人们生活方式的改变,人们的皮肤出现越来越多的问题。比如污染排放,雾霾,粉尘带来的敏感肌肤;还有各种添加剂食品造成的皮肤暗沉,痤疮,粉刺,干燥,起皮;还有劣质化妆品带来的面部重金属残留等等。护肤品的使用过程中,能被有效吸收的才能发挥护肤品该有的功效。
中国专利文献公开号为CN111067845A,专利名称为《一种天然植物多效修复面膜及其制备方法》,采用的原料组份所述粉剂包括(单位为重量份):菊粉0.2-2、沙棘粉0.2-2、大豆低聚肽0.2-2、芦荟凝胶粉0.1-0.12、玫瑰花胶原蛋白0.1-1.5、深海鱼皮胶原蛋白肽0.1-1.5、蜗牛蛋白粉0.1-1.5、苹果醋粉0.1-1、壳聚糖0.01-0.1。所述植物多效修复面膜的制备方法为:精选以上所需的优质原料组份超细化处理,均匀混合分装即可。所述植物多效修复面膜采用具有高生物活性和含多种营养成分的天然原料组份,外用时能够增加细胞活性,改善和消除皮肤暗黄、粗糙,达到美白、防皱的效果。内服时能够达到降低胆固醇、降血脂,防止过氧化脂类物质的形成,促进肠道蠕动,排出体内毒素。所述天然植物多效修复面膜的制备方法简单易行,成本较低,适合大量生产。
中国专利文献公开号为CN106176280A,专利名称为《一种壳聚糖微球保湿抗菌面膜的制备方法》,将壳聚糖加入醋酸溶液中,搅拌均匀,得到壳聚糖溶液;将上述壳聚糖溶液静置,喷雾干燥,得到壳聚糖微球;将壳聚糖微球溶于溶剂中,得到壳聚糖微球溶液,然后喷在面膜纸上,干燥,即得。本发明方法操作简单,反应条件温和,耗时较少,成本低,适用于规模化生产;得到的含壳聚糖微球的面膜有良好的保湿性能和抗菌性,因此具有很高的实用价值和潜在价值。
中国专利文献公开号为CN105919830B,专利名称为《壳聚糖面膜及其制备方法》,包括如下步骤:将果酸溶解于水中得浓度为45-55wt%的果酸溶液;将果酸溶液喷涂至壳聚糖面膜基布上;干燥,干燥后每片壳聚糖面膜基布上含果酸的量为0.08-0.12g;即得所述壳聚糖面膜。本发明改变传统面膜生产和使用方式,本发明壳聚糖面膜的制备方法制备得到的产品为包含果酸的壳聚糖面膜布,产品体积小重量轻(2g左右)。使用时只需加入普通饮用水即可获得面膜进行护肤,方便便捷。
上述专利技术中都提到了用壳聚糖制作面膜的技术,但是由于其制作方法不同,所以,产生的效果不能实现缓释、持续发挥各种原料的功效,从而改善皮肤干裂,粗糙,痘印,痤疮,粉刺,红血丝等问题,修复皮肤,恢复皮肤健康。
发明内容
本发明的目的就是针对现有技术存在的上述缺陷,提供一种壳聚糖多效修复面膜及制备方法,该方法充分利用壳聚糖的结构特性,形成双层胶囊结构,极大加强了各种活性物质的吸收,并且可以缓释,持续发挥各种原料的功效,改善皮肤干裂,粗糙,痘印,痤疮,粉刺,红血丝等问题,修复皮肤,恢复皮肤健康。
本发明提到的一种壳聚糖多效修复面膜,其技术方案是:其组成组分包括如下,按重量份:
壳聚糖1-6份,促成膜物质,1-6份,积雪草提取液1-10份,人参提取液1-10份,薰衣草提取液1-10份,芦荟提取液1-10份,甘油1-10份,透明质酸钠0.01-0.2份,传明酸0.3-2份,三甲基甘氨酸1-10份,泛醇0.1-5份,尿囊素0.1-2份,凝胶剂0.1-5份,防腐剂0.1-0.5份,剩余组分为去离子水补足100份。
本发明提到的壳聚糖多效修复面膜的制备方法,包括以下步骤:
(1)首先将促成膜物质溶于去离子水中,加入适量壳聚糖,搅拌,直到壳聚糖全部溶解;
(2)往其中加入多种植物提取物作为功效成分,搅拌均匀后,得到凝胶状溶液,将该溶液喷雾干燥,得到均一固体A;
(3)将透明质酸钠分散于甘油中,然后加入去离子水溶解,再加入传明酸,三甲基甘氨酸,泛醇,尿囊素搅拌,充分溶解后,边搅拌边加入凝胶剂,得到凝胶B;
(4)将固体A加入到凝胶B中,加入防腐剂,均质化搅拌20分钟,即得到壳聚糖多效修复面膜。
优选的,上述的促成膜物质包括,L-抗坏血酸,水杨酸,柠檬酸或醋酸,用于和壳聚糖发生接枝反应或者溶解壳聚糖,形成凝胶。
优选的,上述的壳聚糖为脱乙酰度95%以上的壳聚糖。
优选的,上述的植物提取液均为经过超临界萃取,固含量大于10%的植物提取液。
优选的,上述的透明质酸钠采用低分子透明质酸钠、高分子透明质酸钠、透明质酸钠交联聚合物、乙酰化透明质酸钠、水解透明质酸钠的一种或几种。
优选的,上述的凝胶剂为丙烯酰胺二甲基牛磺酸铵/VP共聚物,阳离子瓜尔胶,甲基纤维素或明胶。
优选的,均质化搅拌,均质机转速为6000-10000转/分钟。
防腐剂为对羟基苯甲酸酯类,杰马或苯氧乙醇。
与现有技术相比,本发明的有益效果具体如下:
本发明首先将植物提取物和壳聚糖形成微胶囊,壳聚糖微胶囊可以将这些活性成分有效包裹,形成干粉,作为面膜的核心;在胶囊的外部,传明酸有止血美白的功效,主要针对皮肤痤疮粉刺出血,炎症,痘印等症状,三甲基甘氨酸,透明质酸钠,泛醇,作为保湿剂可以提高皮肤的水合作用,软化角质层,让功效性活性成分更容易被皮肤吸收;尿囊素可以促进皮肤生长,加快伤口愈合,缓解和治疗皮肤干燥症;当高分子凝胶剂加入后,高速均质混合物,形成双层微胶囊;在使用面膜的过程中,均匀涂抹于脸部,这个时候,外层的活性成分可以软化皮肤角质层,止血,促渗,让壳聚糖包裹的微胶囊充分渗入皮肤中,被皮肤吸收,其中的人参提取物,积雪草提取物,芦荟提取物,薰衣草提取物分别发挥其美白,淡斑,抗衰,去皱,消炎,修复等功效。而壳聚糖本身的功效也十分强大,壳聚糖可以提高表皮湿度,维持表皮含水量在25%-30%,提高肌肤免疫力,镇静舒缓和修复做过医学美容后的皮肤。可以提高皮肤免疫力,对脆弱、敏感肌肤能在日常的护理中提高肌肤的免疫力。可以镇静舒缓,舒缓外油内干的敏感肌,减轻毛孔堵塞,保持水油平衡。可以修复屏障,做了射频、点阵、果酸等医学美容术之后,壳聚糖能帮助肌肤抗敏感及抗炎症产生,快速修复基底热损伤,避免造成术后敏感。还可以吸附重金属,清洁皮肤。因此,这款壳聚糖多效修复面膜,通过双层吸收体系,先软化皮肤角质层,提高皮肤的吸收能力,然后通过各种活性成分搭配,针对性的修复皮肤,提高皮肤的抵抗力,改变皮肤的粗糙程度,可以帮助消除皮肤细纹,美白,修复损伤,祛痘,消除痘印,修复痘坑,去红血丝,吸附重金属等,让皮肤恢复健康细腻。
本发明充分利用壳聚糖的结构特性,形成双层胶囊结构,极大加强了各种活性物质的吸收,并且可以缓释,持续发挥各种原料的功效,改善皮肤干裂,粗糙,痘印,痤疮,粉刺,红血丝等问题,修复皮肤,恢复皮肤健康。
具体实施方式
以下对本发明的优选实施例进行说明,应当理解,此处所描述的优选实施例仅用于说明和解释本发明,并不用于限定本发明。
实施例1:
本发明提到的一种壳聚糖多效修复面膜,其组成为:壳聚糖3份,L-抗坏血酸4份,积雪草提取液2份,人参提取液2份,薰衣草提取液2份,芦荟提取液5份,甘油6份,透明质酸钠0.1份,传明酸0.5份,三甲基甘氨酸3份,泛醇0.5份,尿囊素0.2份,丙烯酰胺二甲基牛磺酸铵/VP共聚物2份,尼泊金甲酯0.2份,去离子水69.5份。
本发明提到的一种壳聚糖多效修复面膜的制备方法为,包括以下步骤:
取L-抗坏血酸溶于水中,室温搅拌下加入脱乙酰度95%以上的壳聚糖,然后再加入积雪草提取液,人参提取液,薰衣草提取液,芦荟提取液。搅拌均匀得到粘稠溶液,喷雾干燥后得到粉末固体A。
将透明质酸钠分散于甘油中,加入去离子水搅拌,让透明质酸钠充分溶胀,然后,加入传明酸,三甲基甘氨酸,泛醇,尿囊素,升温到60℃溶解,然后加入丙烯酰胺二甲基牛磺酸铵/VP共聚物,搅拌一个小时,得到凝胶B。
将粉末固体A,加入到凝胶B中,然后加入尼泊金甲酯水溶液,均质20分钟,即得到壳聚糖多效修复面膜。
实施例2:
本发明提到的一种壳聚糖多效修复面膜,其组成为:壳聚糖2份,水杨酸2份,薰衣草提取液2份,芦荟提取液5份,马齿苋提取液2份,紫草根提取物2份,甘油5份,透明质酸钠0.1份,传明酸1份,三甲基甘氨酸2份,泛醇1份,尿囊素0.2份,瓜尔胶1份,杰马BP防腐剂0.3份,去离子水74.4份。
本发明提到的一种壳聚糖多效修复面膜的制备方法为,包括以下步骤:
取水杨酸分散于水中,升温到70℃,搅拌下加入脱乙酰度95%以上的壳聚糖,溶解后降温到室温,再加入薰衣草提取液,芦荟提取液,马齿苋提取液,紫草根提取液。搅拌均匀得到粘稠溶液,喷雾干燥后得到粉末固体A。
将透明质酸钠分散于甘油中,加入去离子水搅拌,让透明质酸钠充分溶胀,然后,加入传明酸,三甲基甘氨酸,泛醇,尿囊素,升温到60℃溶解,然后加入瓜尔胶,搅拌一个小时,得到凝胶B。
将粉末固体A,加入到凝胶B中,然后加入杰马BP防腐剂,均质20分钟,即得到壳聚糖多效修复面膜。
实施例3:
本发明提到的一种壳聚糖多效修复面膜,其组成为:壳聚糖3份,柠檬酸2份,玫瑰花提取液5份,金盏花提取液2份,黄瓜提取液5份,人参提取液2份,甘油5份,透明质酸钠0.1份,传明酸0.5份,三甲基甘氨酸2份,泛醇1份,尿囊素0.3份,甲基纤维素2份,杰马BP防腐剂0.2份,去离子水69.9份。
本发明提到的一种壳聚糖多效修复面膜的制备方法为,包括以下步骤:
取柠檬酸溶于水中,室温搅拌下加入脱乙酰度95%以上的壳聚糖,然后再加入玫瑰花提取液,金盏花提取液,黄瓜提取液,人参提取液。搅拌均匀得到粘稠溶液,喷雾干燥后得到粉末固体A。
将透明质酸钠分散于甘油中,加入去离子水搅拌,让透明质酸钠充分溶胀,然后,加入传明酸,三甲基甘氨酸,泛醇,尿囊素,升温到65℃溶解,然后加入甲基纤维素,搅拌一个小时,得到凝胶B。
将粉末固体A,加入到凝胶B中,然后加入杰马BP防腐剂,均质20分钟,即得到壳聚糖多效修复面膜。
实施例4:
本发明提到的一种壳聚糖多效修复面膜,其组成为:壳聚糖1份,白醋10份,迷迭香提取液5份,金缕梅提取液2份,洋甘菊提取液5份,积雪草提取液5份,甘油6份,透明质酸钠0.1份,传明酸1.2份,三甲基甘氨酸2份,泛醇0.5份,尿囊素0.2份,丙烯酰胺二甲基牛磺酸铵/VP共聚物2份,苯氧乙醇0.2份,去离子水69.8份。
本发明提到的一种壳聚糖多效修复面膜的制备方法为,包括以下步骤:
取白醋适量,室温搅拌下加入脱乙酰度95%以上的壳聚糖,然后再加入迷迭香提取液,金缕梅提取液,洋甘菊提取液,积雪草提取液。搅拌均匀得到粘稠溶液,喷雾干燥后得到粉末固体A。
将透明质酸钠分散于甘油中,加入去离子水搅拌,让透明质酸钠充分溶胀,然后,加入传明酸,三甲基甘氨酸,泛醇,尿囊素,升温到60℃溶解,然后加入丙烯酰胺二甲基牛磺酸铵/VP共聚物,搅拌一个小时,得到凝胶B。
将粉末固体A,加入到凝胶B中,然后加入苯氧乙醇防腐剂,均质20分钟,即得到壳聚糖多效修复面膜。
按照膏状面膜的国家检测标准,QB/T2872-2007的要求来检测,检测结果如下:
本发明实施例1-4均可以针对皮肤瘙痒,干燥起皮,红血丝,痤疮粉刺,痘印等症状有良好的效果。其中针对性的,实施案例1经过50名痤疮粉刺患者试用,实施案例2经过10名脸部干燥起皮,过敏症状的患者试用,实施案例3经过10名皮肤重金属色沉患者试用,实施案例4经过10名皮肤红血丝患者试用。使用方法为:受试者每天晚上清洁皮肤后,均匀涂抹该面膜,然后一个小时后清洁皮肤即可。平均一个星期为一个周期,使用四个周期后,对实施例进行评价。其中对所有受试者进行了第一次使用面膜前后的皮肤水分测试,所采用的仪器为Real Bubee,型号RBX-916来测试受试者皮肤的含水量,受试者均为有问题的皮肤患者共80名,使用面膜前平均含水量为28%,使用面膜后,平均含水量为68%。另外,对四组实施例的使用后恢复情况进行评价,评价分级为:痊愈,改善,无变化。其中痊愈标准为实施例1的痘痘消失,实施例2的,皮肤恢复光滑,实施例3的,皮肤色沉消失,实施例4的红血丝消失;改善的标准为实施案例的症状明显减轻;无变化的标准为实施案例的症状没有变化或加重。
评价如下:
经过试用后的结果来看,这种壳聚糖多效修复面膜,针对痤疮粉刺效果明显,说明该壳聚糖多效修复面膜在消炎和控油方面的作用表现优良。针对皮肤干燥起皮,过敏症状效果尤为突出,说明该壳聚糖多效修复面膜在补水保湿方面的作用极佳。针对红血丝,重金属色沉患者,效果优良。
以上所述,仅是本发明的部分较佳实施例,任何熟悉本领域的技术人员均可能利用上述阐述的技术方案加以修改或将其修改为等同的技术方案。因此,依据本发明的技术方案所进行的任何简单修改或等同置换,尽属于本发明要求保护的范围。
Claims (9)
1.一种壳聚糖多效修复面膜,其特征是:其组成组分包括如下,按重量份:
壳聚糖1-6份,促成膜物质,1-6份,积雪草提取液1-10份,人参提取液1-10份,薰衣草提取液1-10份,芦荟提取液1-10份,甘油1-10份,透明质酸钠0.01-0.2份,传明酸0.3-2份,三甲基甘氨酸1-10份,泛醇0.1-5份,尿囊素0.1-2份,凝胶剂0.1-5份,防腐剂0.1-0.5份,剩余组分为去离子水补足100份。
2.根据权利要求1所述的壳聚糖多效修复面膜的制备方法,其特征是包括以下步骤:
(1)首先将促成膜物质溶于去离子水中,加入适量壳聚糖,搅拌,直到壳聚糖全部溶解;
(2)往其中加入多种植物提取物作为功效成分,搅拌均匀后,得到凝胶状溶液,将该溶液喷雾干燥,得到均一固体A;
(3)将透明质酸钠分散于甘油中,然后加入去离子水溶解,再加入传明酸,三甲基甘氨酸,泛醇,尿囊素搅拌,充分溶解后,边搅拌边加入凝胶剂,得到凝胶B;
(4)将固体A加入到凝胶B中,加入防腐剂,均质化搅拌20分钟,即得到壳聚糖多效修复面膜。
3.根据权利要求2所述的壳聚糖多效修复面膜的制备方法,其特征是:所述的促成膜物质包括,L-抗坏血酸,水杨酸,柠檬酸或醋酸,用于和壳聚糖发生接枝反应或者溶解壳聚糖,形成凝胶。
4.根据权利要求2所述的壳聚糖多效修复面膜的制备方法,其特征是:所述的壳聚糖为脱乙酰度95%以上的壳聚糖。
5.根据权利要求2所述的壳聚糖多效修复面膜的制备方法,其特征是:所述的植物提取液均为经过超临界萃取,固含量大于10%的植物提取液。
6.根据权利要求2所述的壳聚糖多效修复面膜的制备方法,其特征是:所述的透明质酸钠采用低分子透明质酸钠、高分子透明质酸钠、透明质酸钠交联聚合物、乙酰化透明质酸钠、水解透明质酸钠的一种或几种。
7.根据权利要求2所述的壳聚糖多效修复面膜的制备方法,其特征是:所述的凝胶剂为丙烯酰胺二甲基牛磺酸铵/VP共聚物,阳离子瓜尔胶,甲基纤维素或明胶。
8.根据权利要求2所述的壳聚糖多效修复面膜的制备方法,其特征是:均质化搅拌,均质机转速为6000-10000转/分钟。
9.根据权利要求2所述的壳聚糖多效修复面膜的制备方法,其特征是:防腐剂为对羟基苯甲酸酯类,杰马或苯氧乙醇。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010987230.7A CN111920742A (zh) | 2020-09-18 | 2020-09-18 | 一种壳聚糖多效修复面膜及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010987230.7A CN111920742A (zh) | 2020-09-18 | 2020-09-18 | 一种壳聚糖多效修复面膜及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111920742A true CN111920742A (zh) | 2020-11-13 |
Family
ID=73333520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010987230.7A Pending CN111920742A (zh) | 2020-09-18 | 2020-09-18 | 一种壳聚糖多效修复面膜及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111920742A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112587657A (zh) * | 2020-12-29 | 2021-04-02 | 山东丽达生物科技集团有限公司 | 促进皮肤健康滋润嫩红的中药生物制剂及其制备方法 |
CN112603993A (zh) * | 2020-12-19 | 2021-04-06 | 江苏诺瓦立医疗用品有限公司 | 一种基于壳聚糖治疗炎性痤疮的凝胶及其制备方法 |
CN115068367A (zh) * | 2022-05-26 | 2022-09-20 | 青岛健康海洋生物制药有限公司 | 一种美容仪专用凝胶及其制备方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100316739A1 (en) * | 2008-01-18 | 2010-12-16 | Ariel Shaul Hasson Nisis | Chitosan gel for dermatological use, production method therefor and use of same |
CN105769698A (zh) * | 2016-04-14 | 2016-07-20 | 曼秀雷敦(中国)药业有限公司 | 一种不含防腐剂的化妆品组合物及其应用 |
CN106138521A (zh) * | 2016-06-28 | 2016-11-23 | 郑州雷曼药业有限公司 | 一种疤痕修复凝胶及其制备方法 |
CN107303253A (zh) * | 2016-04-22 | 2017-10-31 | 长沙星工场生物科技有限公司 | 一种用于受损肌肤的修复剂及其制备方法 |
CN108653019A (zh) * | 2018-07-11 | 2018-10-16 | 高昕文 | 一种温和深层清洁面膜的制备方法 |
CN109288691A (zh) * | 2018-11-02 | 2019-02-01 | 广东墨睿科技有限公司 | 一种石墨烯面膜及其制备方法 |
CN109731021A (zh) * | 2019-03-20 | 2019-05-10 | 武汉市思泰利医疗器械发展有限公司 | 一种用于治疗修复造口皮肤的壳聚糖水凝胶及其制备方法 |
CN111494238A (zh) * | 2020-05-19 | 2020-08-07 | 贵州扬生医用器材有限公司 | 一种含羧化壳聚糖的修复润养面膜及其制备方法 |
-
2020
- 2020-09-18 CN CN202010987230.7A patent/CN111920742A/zh active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100316739A1 (en) * | 2008-01-18 | 2010-12-16 | Ariel Shaul Hasson Nisis | Chitosan gel for dermatological use, production method therefor and use of same |
CN105769698A (zh) * | 2016-04-14 | 2016-07-20 | 曼秀雷敦(中国)药业有限公司 | 一种不含防腐剂的化妆品组合物及其应用 |
CN107303253A (zh) * | 2016-04-22 | 2017-10-31 | 长沙星工场生物科技有限公司 | 一种用于受损肌肤的修复剂及其制备方法 |
CN106138521A (zh) * | 2016-06-28 | 2016-11-23 | 郑州雷曼药业有限公司 | 一种疤痕修复凝胶及其制备方法 |
CN108653019A (zh) * | 2018-07-11 | 2018-10-16 | 高昕文 | 一种温和深层清洁面膜的制备方法 |
CN109288691A (zh) * | 2018-11-02 | 2019-02-01 | 广东墨睿科技有限公司 | 一种石墨烯面膜及其制备方法 |
CN109731021A (zh) * | 2019-03-20 | 2019-05-10 | 武汉市思泰利医疗器械发展有限公司 | 一种用于治疗修复造口皮肤的壳聚糖水凝胶及其制备方法 |
CN111494238A (zh) * | 2020-05-19 | 2020-08-07 | 贵州扬生医用器材有限公司 | 一种含羧化壳聚糖的修复润养面膜及其制备方法 |
Non-Patent Citations (2)
Title |
---|
广州优聚生物制品有限公司: "新妆宜面壳聚糖保湿亮肤面膜", 《HTTP://FTBA.NMPA.GOV.CN:8181/FTBAN/ITOWNET/HZP_BA/FW/PZ.JSP?PROCESSID=201603151550000WNDH&NID=201603151550000WNDH》 * |
王正坤: "《医学美容与皮肤保养》", 31 January 2014, 台海出版社 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112603993A (zh) * | 2020-12-19 | 2021-04-06 | 江苏诺瓦立医疗用品有限公司 | 一种基于壳聚糖治疗炎性痤疮的凝胶及其制备方法 |
CN112587657A (zh) * | 2020-12-29 | 2021-04-02 | 山东丽达生物科技集团有限公司 | 促进皮肤健康滋润嫩红的中药生物制剂及其制备方法 |
CN115068367A (zh) * | 2022-05-26 | 2022-09-20 | 青岛健康海洋生物制药有限公司 | 一种美容仪专用凝胶及其制备方法 |
CN115068367B (zh) * | 2022-05-26 | 2023-05-05 | 青岛健康海洋生物制药有限公司 | 一种美容仪专用凝胶及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111920742A (zh) | 一种壳聚糖多效修复面膜及制备方法 | |
US9023369B2 (en) | Freeze-dried composition of active substances | |
CN109674734A (zh) | 一种具有保湿、修护、舒缓、抗衰作用的组合成分及其应用 | |
TW200836755A (en) | Marine algae extract comprising low degree of polymerization marine algae polysaccharides, and the preparation process and uses thereof | |
CN107496325A (zh) | 含牡丹精油、青瓜提取液和蜗牛原液的面膜及其制备方法 | |
CN102178636A (zh) | 一种用于细致毛孔的海洋生物功能化妆品 | |
CN104434768A (zh) | 一种具有缓释功效的保湿化妆水及其制备方法 | |
CN103083214A (zh) | 一种芦荟保湿液及应用 | |
CN107157880A (zh) | 一种金钗石斛补水睡眠面膜及其制备方法 | |
CN112656740A (zh) | 一种含有人参提取物的敷料的制备方法及应用 | |
CN110882169A (zh) | 一种美白祛斑的溶化面膜及其制备方法 | |
EP2819641B1 (en) | Personal care compositions with acidified pectins | |
JP2008255066A (ja) | 新規パック用化粧品組成物 | |
CN106726757B (zh) | 一种牡丹籽油微乳凝胶剂及其制备方法 | |
CN113332196A (zh) | 一种用于皮肤深层修复的绿茶多酚修复凝胶及其制备方法 | |
CN107519118A (zh) | 一种蛇胆眼膜及其制备方法 | |
WO2020062388A1 (zh) | 一种新会柑花萃取液制作面膜的配方及工艺 | |
CN117137834A (zh) | 一种祛黑头化妆品组合物及其制备方法 | |
US9023333B2 (en) | Method of using shaped articles to apply a scaffold-forming agent to an external skin and/or hair surface of a human or an animal | |
CN113797150A (zh) | 一种透明质酸胶原蛋白面膜的配方及其制作方法 | |
CN112675071A (zh) | 一种羊毛角蛋白冻干面膜及其制备方法和应用 | |
CN113069377A (zh) | 一种抗衰老面霜及其制备方法 | |
CN115364014A (zh) | 一种多效保湿因子及其制备方法 | |
CN117100669A (zh) | 一种喷雾式补水保湿面膜及制备方法和使用方法 | |
KR20150076502A (ko) | 워시 오프 타입 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201113 |
|
RJ01 | Rejection of invention patent application after publication |